Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Bhatia

Showing results (51-60 of 220) with videos related to

Pageof 22
Sort By:
British Journal of Haematology|May 5, 2022
Hypomethylating agent/venetoclax versus intensive chemotherapy in adults with relapsed or refractory acute myeloid leukaemiaOmer Jamy, Karen Lin, Sarah Worth, et al.
Leukemia Research|April 17, 2012
Deferasirox exposure induces reactive oxygen species and reduces growth and viability of myelodysplastic hematopoietic progenitorsVinod Pullarkat, Arjun Sehgal, Liang Li, et al.
The Journal of Clinical Investigation|February 16, 2016
Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cellsBin Zhang, Ling Li, Yinwei Ho, et al.
Journal of Adolescent and Young Adult Oncology|January 20, 2022
Safe and Effective Use of Imatinib to Treat Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia During PregnancySarah Ashraf, Julie Wolfson, Pankit Vachhani, et al.
Biotechnology Progress|August 5, 2020
Sensitivity of a PER.C6® cell line to bis(2,4-di-tert-butylphenyl)phosphate and evaluation of a new, biocompatible single-use filmJoshua R Jachuck, Soumya Mohanan Krishnathu, Jeffrey E Landau, et al.
The Journal of Invasive Cardiology|September 4, 2009
Causes of death in patients undergoing percutaneous coronary intervention with drug-eluting stents in a real-world settingMichael S Lee, Timothy Canan, Alice Perlowski, et al.
Blood|March 10, 2007
Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cellsHardik Modi, Tinisha McDonald, Su Chu, et al.
The Journal of Invasive Cardiology|May 5, 2009
Preprocedural white blood cell count as a predictor of death and major adverse cardiac events in patients undergoing percutaneous coronary intervention with drug-eluting stentsDaniel L Jurewitz, Antonio Pessegueiro, Raymond Zimmer, et al.
Journal of Proteome Research|April 23, 2011
NMR-based metabolomic analysis of the molecular pathogenesis of therapy-related myelodysplasia/acute myeloid leukemiaKristin E Cano, Liang Li, Smita Bhatia, et al.
Cancer Research|August 4, 2004
Effect of mutational inactivation of tyrosine kinase activity on BCR/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitorsPandurangan Ramaraj, Harjeet Singh, Ning Niu, et al.
Pageof 22

Showing results (51-60 of 220) with videos related to

Sort By:
Pageof 22
British Journal of Haematology|May 5, 2022
Hypomethylating agent/venetoclax versus intensive chemotherapy in adults with relapsed or refractory acute myeloid leukaemiaOmer Jamy, Karen Lin, Sarah Worth, et al.
Leukemia Research|April 17, 2012
Deferasirox exposure induces reactive oxygen species and reduces growth and viability of myelodysplastic hematopoietic progenitorsVinod Pullarkat, Arjun Sehgal, Liang Li, et al.
The Journal of Clinical Investigation|February 16, 2016
Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cellsBin Zhang, Ling Li, Yinwei Ho, et al.
Journal of Adolescent and Young Adult Oncology|January 20, 2022
Safe and Effective Use of Imatinib to Treat Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia During PregnancySarah Ashraf, Julie Wolfson, Pankit Vachhani, et al.
Biotechnology Progress|August 5, 2020
Sensitivity of a PER.C6® cell line to bis(2,4-di-tert-butylphenyl)phosphate and evaluation of a new, biocompatible single-use filmJoshua R Jachuck, Soumya Mohanan Krishnathu, Jeffrey E Landau, et al.
The Journal of Invasive Cardiology|September 4, 2009
Causes of death in patients undergoing percutaneous coronary intervention with drug-eluting stents in a real-world settingMichael S Lee, Timothy Canan, Alice Perlowski, et al.
Blood|March 10, 2007
Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cellsHardik Modi, Tinisha McDonald, Su Chu, et al.
The Journal of Invasive Cardiology|May 5, 2009
Preprocedural white blood cell count as a predictor of death and major adverse cardiac events in patients undergoing percutaneous coronary intervention with drug-eluting stentsDaniel L Jurewitz, Antonio Pessegueiro, Raymond Zimmer, et al.
Journal of Proteome Research|April 23, 2011
NMR-based metabolomic analysis of the molecular pathogenesis of therapy-related myelodysplasia/acute myeloid leukemiaKristin E Cano, Liang Li, Smita Bhatia, et al.
Cancer Research|August 4, 2004
Effect of mutational inactivation of tyrosine kinase activity on BCR/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitorsPandurangan Ramaraj, Harjeet Singh, Ning Niu, et al.
Pageof 22